Freedom Capital Markets Maintains Buy on Inspire Medical Systems, Lowers Price Target to $93
Benzinga Newsdesk 10 hours ago
Analyst RatingsNewsPrice Target
Freedom Capital Markets analyst Keith Hinton maintains Inspire Medical Systems (NYSE:INSP) with a Buy and lowers the price target from $97 to $93.
Freedom Capital Markets analyst Keith Hinton maintains Inspire Medical Systems (NYSE:INSP) with a Buy and lowers the price target from $97 to $93.